Latest News of MRSN
Mersana Therapeutics Inc (MRSN) Q3 2024 Earnings Call Highlights: Strategic Advances and ...
By Yahoo! Finance |
3 weeks ago
The CEO mentions that specific patient numbers and biomarker data for XMT-1660 will be shared later this year. The company is exploring more frequent dosing schedules and assessing prior treatment his...